Pages

Monday, 23 August 2021

Trillium Therapeutics shares soar on Pfizer’s $2.26B deal


Trillium Therapeutics shares soar on Pfizer’s $2.26B deal



Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)